173 related articles for article (PubMed ID: 35878018)
21. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
Limaye V; Bundell C; Hollingsworth P; Rojana-Udomsart A; Mastaglia F; Blumbergs P; Lester S
Muscle Nerve; 2015 Aug; 52(2):196-203. PubMed ID: 25521389
[TBL] [Abstract][Full Text] [Related]
22. Detection of Myositis Autoantibodies by Multi-Analytic Immunoassays in a Large Multicenter Cohort of Patients with Definite Idiopathic Inflammatory Myopathies.
Ghirardello A; Gatto M; Franco C; Zanatta E; Padoan R; Ienna L; Gallo N; Zen M; Lundberg IE; Mahler M; Doria A; Iaccarino L
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835823
[TBL] [Abstract][Full Text] [Related]
23. An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations.
Fredi M; Cavazzana I; Ceribelli A; Cavagna L; Barsotti S; Bartoloni E; Benucci M; De Stefano L; Doria A; Emmi G; Fabris M; Fornaro M; Furini F; Giudizi MG; Govoni M; Ghirardello A; Iaccarino L; Iannone F; Infantino M; Isailovic N; Lazzaroni MG; Manfredi M; Mathieu A; Marasco E; Migliorini P; Montecucco C; Palterer B; Parronchi P; Piga M; Pratesi F; Riccieri V; Selmi C; Tampoia M; Tripoli A; Zanframundo G; Radice A; Gerli R; Franceschini F;
Clin Rev Allergy Immunol; 2022 Oct; 63(2):240-250. PubMed ID: 35092577
[TBL] [Abstract][Full Text] [Related]
24. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of clinical characteristics and laboratory parameters of patients with dermatomyositis-specific autoantibodies and autoantibody-negative patients].
Bodoki L; Budai D; Nagy-Vincze M; Griger Z; Betteridge Z; Dankó K
Orv Hetil; 2015 Sep; 156(36):1451-9. PubMed ID: 26320599
[TBL] [Abstract][Full Text] [Related]
26. Association Between Autoantibody Phenotype and Cutaneous Adverse Reactions to Hydroxychloroquine in Dermatomyositis.
Wolstencroft PW; Casciola-Rosen L; Fiorentino DF
JAMA Dermatol; 2018 Oct; 154(10):1199-1203. PubMed ID: 30140893
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated myositis before and after the COVID-19 pandemic onset: a changing trend.
Costa FM; Campanilho-Marques R; Dourado E; Bandeira M; Correia B; Melo AT; Saraiva F; Barreira SC; Fonseca JE
Clin Exp Rheumatol; 2024 Feb; 42(2):316-320. PubMed ID: 38488097
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies Recognizing Specificity Protein 4 Co-occur With Anti-Transcription Intermediary Factor 1 and Are Associated With Distinct Clinical Features and Immunogenetic Risk Factors in Juvenile Myositis.
Sherman MA; Pak K; Pinal-Fernandez I; Flegel WA; Targoff IN; Miller FW; Rider LG; Mammen AL;
Arthritis Rheumatol; 2023 Sep; 75(9):1668-1677. PubMed ID: 36996276
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
[TBL] [Abstract][Full Text] [Related]
30. Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis.
Okiyama N; Ichimura Y; Shobo M; Tanaka R; Kubota N; Saito A; Ishitsuka Y; Watanabe R; Fujisawa Y; Nakamura Y; Murakami A; Kayama H; Takeda K; Fujimoto M
Ann Rheum Dis; 2021 Sep; 80(9):1201-1208. PubMed ID: 33811031
[TBL] [Abstract][Full Text] [Related]
31. Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.
Zampeli E; Venetsanopoulou A; Argyropoulou OD; Mavragani CP; Tektonidou MG; Vlachoyiannopoulos PG; Tzioufas AG; Skopouli FN; Moutsopoulos HM
Clin Rheumatol; 2019 Jan; 38(1):125-132. PubMed ID: 30145635
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of polymyalgia rheumatica in a cohort of patients with idiopathic inflammatory myopathy.
Douglass-Molloy H; Limaye V
Clin Rheumatol; 2020 Apr; 39(4):1217-1221. PubMed ID: 31919772
[TBL] [Abstract][Full Text] [Related]
33. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
34. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis.
Shamim EA; Rider LG; Pandey JP; O'Hanlon TP; Jara LJ; Samayoa EA; Burgos-Vargas R; Vazquez-Mellado J; Alcocer-Varela J; Salazar-Paramo M; Kutzbach AG; Malley JD; Targoff IN; Garcia-De la Torre I; Miller FW
Arthritis Rheum; 2002 Jul; 46(7):1885-93. PubMed ID: 12124873
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of myositis-specific autoantibodies.
Nakashima R
Immunol Med; 2018 Sep; 41(3):103-112. PubMed ID: 30938275
[TBL] [Abstract][Full Text] [Related]
36. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
[TBL] [Abstract][Full Text] [Related]
37. A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients.
Sumazaki M; Kaneko K; Ito M; Oshima Y; Saito F; Ogata H; Shibuya K; Shimada H
Am J Case Rep; 2020 Apr; 21():e922004. PubMed ID: 32312948
[TBL] [Abstract][Full Text] [Related]
38. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
39. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
40. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
